Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Safety of Estrogens in Lupus: Hormone Replacement Therapy

ClinicalTrials.gov ID: NCT00000419

Public ClinicalTrials.gov record NCT00000419. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:44 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Safety of Estrogens in Lupus Erythematosus - National Assessment (SELENA): Hormone Replacement Therapy

Study identification

NCT ID
NCT00000419
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
NYU Langone Health
Other
Enrollment
350 participants

Conditions and interventions

Interventions

  • Premarin and Provera Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 1996
Primary completion
Not listed
Completion
Jul 31, 2002
Last update posted
May 2, 2013

1996 – 2002

United States locations

U.S. sites
16
U.S. states
13
U.S. cities
15
Facility City State ZIP Site status
UAB Medical Center Birmingham Alabama 35294
UCLA Medical Center, Dept. of Rheumatology Los Angeles California 90024
University of Chicago Pritzker School of Medicine Chicago Illinois 60637
Louisiana School of Medicine Shreveport Louisiana 71130-3932
Johns Hopkins Hospital Baltimore Maryland 21205
Univ. of Michigan Med. Ctr., Rheumatology Div. Ann Arbor Michigan 48109-0358
Hospital for Joint Diseases New York New York 10003
Hospital for Special Surgery New York New York 10021
Albert Einstein College of Medicine, Jacoby Hospital, Dept. of Rheumatology The Bronx New York 10461
UNC Medical Center, Dept. of Rheumatology Chapel Hill North Carolina 27599-7280
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104
Univ. of Pennsylvania Medical Center Philadelphia Pennsylvania 19104
Univ. of Pittsburgh, Dept. of Rheumatology Pittsburgh Pennsylvania 15213
University of Texas Health Sciences Center Houston Texas 77030
Medical College of Virginia, Ambulatory Care Center Richmond Virginia 23219
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00000419, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 2, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00000419 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →